| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.742 | 6.057 | 5.790 | 5.867 | 6.259 | 9.158 | 8.106 | 8.956 | - | - |
| Total Income - EUR | 5.742 | 6.057 | 5.790 | 5.867 | 6.259 | 9.158 | 8.106 | 10.919 | - | - |
| Total Expenses - EUR | 955 | 1.045 | 1.100 | 1.885 | 957 | 1.440 | 771 | 3.123 | - | - |
| Gross Profit/Loss - EUR | 4.788 | 5.012 | 4.690 | 3.982 | 5.302 | 7.718 | 7.335 | 7.796 | - | - |
| Net Profit/Loss - EUR | 4.615 | 4.830 | 4.516 | 3.805 | 5.114 | 7.443 | 7.121 | 7.554 | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Publigenom Cont Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Current Assets | 14.660 | 10.956 | 14.871 | 18.342 | 19.915 | 21.901 | 28.217 | 29.990 | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | 0 | 423 | 285 | 312 | 369 | 310 | 20 | 232 | - | - |
| Cash | 14.660 | 10.532 | 14.586 | 18.030 | 19.546 | 21.591 | 28.196 | 29.758 | - | - |
| Shareholders Funds | 14.613 | 10.387 | 14.726 | 18.261 | 19.694 | 21.541 | 28.184 | 29.636 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 47 | 569 | 144 | 81 | 221 | 360 | 32 | 354 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6920 - 6920" | |||||||||
| CAEN Financial Year |
6920
|
|||||||||
Comments - Publigenom Cont Srl